Judit Cselenyák

Title: **Innovations by Judit Cselenyák in Pharmaceutical Chemistry**

Introduction

Judit Cselenyák is an accomplished inventor based in Budapest, Hungary. She has made significant contributions in the field of pharmaceutical chemistry, particularly with a focus on developing novel compounds that could have therapeutic applications. Her innovative work has been recognized in the form of a patent, showcasing her expertise and the potential impact of her research.

Latest Patents

Judit holds a patent for "8-substituted-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepine derivatives, as AMPA/kainate receptor inhibitors." This patent discloses a novel 8-substituted compound alongside its pharmaceutically acceptable quaternary ammonium salts. The patent also details a process for the synthesis of these compounds, as well as a pharmaceutical composition containing them. The unique properties of these compounds as competitive AMPA/kainate antagonists position them as promising candidates for treating diseases where receptor inhibition is beneficial.

Career Highlights

Judit is currently employed at Egis Gyógyszergyár Rt., a leading pharmaceutical company in Hungary. Her role involves extensive research and development, leading to advancements in drug formulations and therapeutic methodologies. The success of her patent reflects her dedication to scientific innovation and the potential real-world applications of her work.

Collaborations

Throughout her career, Judit has collaborated with esteemed colleagues, including László Balázs and József Barkóczy. These collaborations enhance the multidisciplinary approach to her research, fostering an environment of shared knowledge and expertise that is crucial in the complex field of pharmaceutical development.

Conclusion

Judit Cselenyák stands out as a pioneering inventor in the realm of pharmaceutical innovations. With her focused research and collaborative efforts, she continues to pave the way for new treatments, contributing to the advancement of medicine and improving patient outcomes. Her patent serves as a testament to her ingenuity and the importance of supporting innovatory individuals in the scientific community.